Browse > Article
http://dx.doi.org/10.24304/kjcp.2021.31.1.12

Sports Pharmacy: New Specialty of Pharmacists and Pharmaceutical Care Services  

Kim, Sung Hwa (Graduate School of Pharmaceutical Sciences, Ewha Womans University)
Cho, Sora (College of Pharmacy, Ewha Womans University)
Choi, Jae Hee (Division of Life and Pharmaceutical Sciences, Ewha Womans University)
Lee, Young-Hee (Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine)
Rhie, Sandy Jeong (Graduate School of Pharmaceutical Sciences, Ewha Womans University)
Publication Information
Korean Journal of Clinical Pharmacy / v.31, no.1, 2021 , pp. 12-20 More about this Journal
Abstract
The World Anti-Doping Agency has made efforts to promote the safe use of medications and prevent doping in sports globally. International standards have been established and experts have advocate anti-doping education to athletes and healthcare professionals. Pharmacists are expected to participate in the pharmaceutical care activity of sports medicine in protecting the athletes while providing the spirits of clean sports. In this review, we described the pharmacists' roles and functions in six areas of sports pharmaceutical care: awareness, treatment, prevention, optimization, abuse, and monitoring. Sports pharmacists should be able to prevent inappropriate drug use and manage athletes' illness and injury using pharmacotherapy. Further pharmacists should actively involve to educate and counsel athletes, trainers, and healthcare teams. In conclusion, pharmacists are expected to play important roles in sports pharmacy, which is the emerging area of specialized pharmaceutical care services.
Keywords
Sports pharmacy; sports pharmacist; specialized pharmaceutical service;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sagoe D, Holden G, Rise ENK. Doping prevention through anti-doping education and practical strength training: The Hercules program. Performance Enhancement and Health 2016;5(1):24-30.   DOI
2 Mottram D, Khalifa S, Alemrayat B, et al. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports. J Sports Med Phys Fitness 2016;56(6):817-24.
3 Yee KC, De Marco M, Salahudeen MS, et al. Pharmacists as a source of advice on medication use for athletes. Pharmacy 2020;8(1):10.   DOI
4 Hainline B, Derman W, Vernec A, et al. International Olympic Committee consensus statement on pain management in elite athletes. Br J Sports Med 2014;51(17):1245-58.   DOI
5 Ferry B, DeCastro A, Bragg S. Common prescription medications used in athletes. Prim Care 2020;47(1):49-64.   DOI
6 Matava MJ. Injectable nonsteroidal anti-inflammatory drugs in sport. Clin J Sport Med 2018;28(5):443-50.   DOI
7 Alaranta A, Alaranta H, Helenius I. Use of prescription drugs in athletes. Sports Med 2008;38(6):449-63.   DOI
8 Golzari H, Dawson NV, Speroff T, Thomas C. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med 2007;71(7):389-97.
9 WADA. International standard for education (ISE) 2021. Available from https://www.wada-ama.org/en/resources/the-code/internationalstandard-for-education-ise. Accessed February 6, 2021.
10 Mottram D, Stuart M. The emerging specialty of sports pharmacy ASPETAR-Sports Medicine Journal 2013;1:66-71.
11 Gleeson M, Pyne DB. Respiratory inflammation and infections in high-performance athletes. Immuno Cell Biol 2016;94(2):124-31.   DOI
12 Asplund C. Treatment of hypertension in athletes: an evidence-based review. Phys Sportsmed 2010;38(1):37-44.   DOI
13 Pelto H. Hypertensive medications in competitive athletes. Curr Sports Med Rep 2017;16(1):45-9.   DOI
14 KADA. Therapeutic use exemption. Available from https://kadaad.or.kr/kada?where=tue/tue_intro. Accessed February 6, 2021.
15 Kaufman KR. Anticonvulsants in sports: ethical considerations. Epilepsy Behav 2007;10(2):268-71.   DOI
16 Wheeler P, Batt M. Do non-steroidal anti-inflammatory drugs adversely affect stress fracture healing? a short review. Br J Sports Med 2005;39(2):65-9.   DOI
17 Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Int J Sport Nutr Exerc Metab 2018;28(2):104-25.   DOI
18 Howard MS, DiDonato KL, Janovick DL, et al. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: an exploratory study. J Am Pharm Assoc 2018;58(4S): S30-S36.e2.   DOI
19 Edenfield KM. Sports Supplements: Pearls and Pitfalls. Prim Care 2020;47(1):37-48.   DOI
20 Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015;(2):CD006895.
21 Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019;380(1):11-22.   DOI
22 Martinez-Sanz JM, Sospedra I, Ortiz CM, Baladia E, Gil-Izquierdo A, Ortiz-Moncada R. Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports. Nutrients 2017;9(10):1093.   DOI
23 Barrett EC, McBurney MI, Ciappio ED. ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr 2014;5(3):268-77.   DOI
24 Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardio 2016;67(1):22-7.   DOI
25 Lewis NA, Daniels D, Calder PC, Castell LM, Pedlar CR. Are there benefits from the use of fish oil supplements in athletes? A systematic review. Adv Nutr 2020;11(5):1300-14.   DOI
26 Ganio MS, Klau JF, Casa DJ, Armstrong LE, Maresh CM. Effect of caffeine on sport-specific endurance performance: a systematic review. J Strength Cond Res 2009;23(1):315-24.   DOI
27 Peeling P, Binnie MJ, Goods PS, Sim M, Burke LM. Evidence-based supplements for the enhancement of athletic performance. Int J Sport Nutr Exerc Metab 2018;28(2):178-87.   DOI
28 Kondric M, Sekulic D, Petroczi A, Ostojic L, Rodek J, Ostojic Z. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach. Subst Abuse Treat Prev Policy 2011;6:27.   DOI
29 Gaffney GR, Parisotto R. Gene doping: a review of performance-enhancing genetics. Pediatr Clin North Am 2007;54(4):807-22.   DOI
30 van der Gronde T, de Hon O, Haisma HJ, Pieters T. Gene doping: an overview and current implications for athletes. Br J Sports Med 2013;47(11):670-8.   DOI
31 Hatton CK, Green GA, Ambrose PJ. Performance-enhancing drugs: understanding the risks. Phys Med Rehabil Clin N Am 2014;25(4): 897-913.   DOI
32 Tandon S, Bowers LD, Fedoruk MN. Treating the elite athlete: anti-doping information for the health professional. Mo Med 2015; 112(2):122-8.
33 Gamelin F-X, Cuvelier G, Mendes A, et al. Cannabidiol in sport: Ergogenic or else? Pharmacol Res 2020;156:104764.   DOI
34 Scharf M, Zurawski N, Ruthenberg T. Negotiating privacy. Athletes' assessment and knowledge of the ADAMS. Perform Enhanc Health 2018;6(2):59-68.   DOI
35 Stuart M, Kwon YI, Rhie SJ. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic winter games. Br J Sports Med 2019;53(17):1105-10.   DOI
36 Hyun J. Geneticizing ethnicity and diet: Anti-doping science and Its social impact in the age of post-genomics. Front Genet 2017;8:56.   DOI
37 Webborn N, Williams A, McNamee M, et al. Direct-to-consumer genetic testing for predicting sports performance and talent identification: consensus statement. Br J Sports Med 2015;49(23):1486-91.   DOI
38 Hooper AD, Cooper JM, Schneider J, Kairuz T. Current and potential roles in sports pharmacy: A systematic review. Pharmacy (Basel) 2019;7(1):29.   DOI
39 Bomfim JHGG. Pharmaceutical Care in Sports. Pharmacy (Basel) 2020;8(4):218.   DOI
40 Ambrose PJ. An advanced pharmacy practice experience in sports pharmacy. Am J Pharm Educ 2008;72(1):19.   DOI
41 Sipaviciute B, Sukys S, Dumciene A. Doping prevention in sport: Overview of anti-doping education programmes. Balt J Sport Health Sci 2020;2(117).
42 Gatterer K, Gumpenberger M, Overbye M, Streicher B, Schobersberger W, Blank C. An evaluation of prevention initiatives by 53 national anti-doping organizations: achievements and limitations. J Sport Health Sci 2020;9(3):228-39.   DOI
43 Ambrose PJ. Educational opportunities and anti-doping roles and responsibilities for pharmacists. Yakugaku Zasshi 2011;131(12):1761-4.   DOI
44 Wang G, Karanikolou A, Verdouka I, Friedmann T, Pitsiladis Y. Next generation "omics" approaches in the "fight" against blood doping. Med Sport Sci 2017;62:119-28.   DOI
45 Backhouse SH, McKenna J. Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs. Inter J Drug Policy 2011;22(3):198-202.   DOI
46 Auersperger I, Topic MD, Maver P, Pusnik VK, Osredkar J, Lainscak M. Doping awareness, views, and experience: a comparison between general practitioners and pharmacists. Wien Klin Wochenschr 2012;124(1-2):32-8.   DOI
47 WADA. Prohibited list 2021. Available from https://www.wadaama.org/en/what-we-do/the-prohibited-list. Accessed February 6, 2021.
48 Malve HO. Sports pharmacology: a medical pharmacologist's perspective. J Pharm Bioallied Sci 2018;10(3):126-36.   DOI
49 Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: The Adolescents Training and Learning to Avoid Steroids (ATLAS) program. JAMA 1996;276(19):1555-62.   DOI